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status and hepatic steatosis found in our study
may thus reflect the changes in fat distribution
during menopausal transition.
Causal diagrams enable the accurate selec-
tion of covariables from a variety of potential
variables influencing the studied association. It
has been shown that an arbitrary inclusion of
variables in multivariable models may not only
lead to an underestimation of the association
of interest but also introduce bias in the
analyses.5 According to our directed acyclic
graphs, metabolic factors should be regarded as
mediators rather than confounders for the
relationship investigated.
We conclude that menopausal status is
associated with hepatic steatosis. The prognos-
tic relevance of this association with respect to
incident cardiovascular disease and diabetes
has to be proved.
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Association between Helicobacter
pylori infection and interleukin 1b
polymorphism predispose to CpG
island methylation in gastric
cancer
Interleukin1b (IL1b) is upregulated in the
presence of Helicobacter pylori infection.1 IL1b
polymorphisms with T/T and T/C genotypes
enhance IL1b production, and are associated
with an increased risk of H pylori-induced
hypochlorhydria2 and gastric cancer.3 The
relationship between H pylori and CpG island
methylation has been repeatedly reported.4–6 It
has been reported that IL1b can modulate CpG
island methylation through activation of DNA
methyltransferase and hence repress gene
expression.7 We therefore hypothesised that
patients with H pylori infection and IL1 poly-
morphism, by the production of IL1b, are
predisposed to gastric cancer development
through the CpG island methylation pathway.
We obtained surgical specimens and their
corresponding peripheral blood from 98 con-
secutive patients with gastric cancer admitted
to Queen Mary Hospital, Hong Kong. This
study was approved by the ethics committee.
The methylation status of the death-associated
protein-kinase, O6-methyl-guanine methyl-
Figure 1 Causal diagram for the association between menopause and hepatic steatosis. (A) A minimum set of confounders would include age, smoking
status and unmeasured confounders such as common genetic factors. (B) In contrast with (A), the diagram considers additional causal effects of alcohol
consumption and nutrition on menopausal status (dotted arrows). In this scenario, a minimum set of confounders would include age, smoking status,
nutritional factors, alcohol consumption and unmeasured confounders such as common genetic factors.
Funding: This work is part of the Community Medicine
Research (CMR) net of the University of Greifswald,
Germany, which is funded by the Federal Ministry of
Education and Research (grant no. ZZ9603), the
Ministry of Cultural Affairs and the Social Ministry of
the Federal State of Mecklenburg-West Pomerania. The
CMR encompasses several research projects, which are
sharing data of the population-based Study of Health in
Pomerania (http://www.community-medicine.de).
Competing interests: None.
PostScript 595
www.gutjnl.com
 on 2 October 2008 gut.bmj.comDownloaded from 
transferase, p16 genes8 and E-cadherin9 pro-
moter was determined by methylation-specific
polymerase chain reaction. Genotyping of IL1
polymorphism was performed as reported
previously.2 10 H pylori status was determined
by serology using a commercially available
ELISA kit (pylori DTect ELISA, Diagnostic
Technology Pty, New South Wales, Australia)
and histology using Giemsa stain. H pylori
status was considered to be positive if either
test showed a positive result.
H pylori infection was present in 65% (64) of
patients. In the IL1b gene, the T and C alleles at
the -511 locus of the IL1b gene were in near
total linkage disequilibrium with the C and T
alleles at the -31 locus. Analysis was therefore
restricted to the IL1b-511 locus, but the
associations with the -31 locus were identical.
The allele frequencies at IL1b-511 were 16%
(16), 59% (58) and 25% (24) for C/C, C/T and T/
T genotypes, respectively. Methylation of
methylguanine-DNA methyltransferase, E-cad-
herin, death-associated protein and p16 was
present in 30% (29), 59% (58), 43% (42) and
45% (44) of patients, respectively (examples
shown in fig 1). Patients with the T/T or T/C
genotype showed an increased odds ratio (OR)
of 6.4 and 3.7, respectively, with respect to the
C/C genotype for developing methylation at
two or more genes (table 1). This OR for
developing methylation at two or more genes
was markedly increased in patients with H
pylori infection and with the T/T (12.5) or T/C
(5.6) genotype with respect to the C/C genotype
but was not present in patients without H pylori
infection. However, no association of the
genotype on an individual methylation marker
was seen (table 1). Also, there was no
association between the number of genes
methylated and H pylori status, no difference
in age between those with or without methyla-
tion at two or more genes, and anatomical site,
except that lower stages (stages I and II) were
associated with more frequent methylation at
two or more genes (table 1).
The underlying mechanisms or the environ-
mental factors governing the simultaneous
methylation of multiple genes in gastric cancer
are still unclear. Hmadcha et al7 have reported
gene silencing due to methylation at the CpG
island in the presence of IL1b. We have
previously reported that eradication of H pylori
may result in reversal of methylation at tumour
suppressor genes in non-lesional gastric
mucosa.5 Our study may further support the
idea that H pylori infection stimulates the
production of IL1b, and the presence of
the proinflammatory T allele further enhances
the production of IL1b. The synergistic effect of
these two factors was observed in our study to
correlate with the increased frequency of
methylated genes. Thus, patients with H pylori
infection and IL1b-511 T/T genotype may be
predisposed to gastric cancer through the CpG
island methylation pathway.
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Table 1 Correlation between methylation at two or more genes and IL1b-511 genotype, and other tumour characteristics
Less than two genes methylated Two or more genes methylated OR 95% CI
Locus at IL1b-511 (whole group, n = 98), overall p = 0.02
C/C 56.2% (9) 43.8% (7) 1
C/T 25.9% (15) 74.1% (43) 3.7 1.2 to 12.1
T/T 16.7% (4) 83.3% (20) 6.4 1.6 to 30.7
Locus at IL1b-511 (H pylori positive, n = 64) overall p = 0.03
C/C 62.5% (5) 37.5% (3) 1
C/T 23.1% (9) 76.9% (30) 5.6 1.2 to 31.7
T/T 11.8% (2) 88.2% (15) 12.5 1.8 to 125.7
Locus at IL1b-511 (H pylori negative, n = 34), overall p = 0.61
C/C 50% (4) 50% (4) 1
C/T 31.6% (6) 68.4% (13) 2.2 0.4 to 12.4
T/T 28.6% (2) 71.4% (5) 2.5 0.3 to 25.9
H pylori status, overall p = 0.29
+ 25% (16) 75% (48) 1.6 0.7 to 4
2 35% (12) 65% (22) 1
Patient age (years), overall p = 0.44
(60 23% (7) 77% (23) 1
.60 31% (21) 69% (47) 0.7 0.2 to 1.7
Tumour stage, overall p = 0.004
I and II 12.8% (5) 87.2% (34)
III and IV 39% (23) 61% (36) 0.23 0.07 to 0.63
Anatomical site, overall p = 0.55
Antrum 27% (20) 73% (54) 1
Non-antrum 33.3% (8) 66.7% (16) 0.7 0.3 to 2
Histology (Lauren’s classification), overall p = 0.09
Intestinal 21.2% (11) 78.8% (42) 1
Diffuse 32.3% (10) 67.7% (21) 0.55 0.2 to 1.5
Mixed 50.0% (7) 50.0% (7) 0.26 0.1 to 0.9
Methylation status stratified by genotype
H pylori positive H pylori negative
C/C 62.5% (5/8) 50% (4/8) 0.6 0.07 to 4.4 (p = 0.61)
C/T 23% (9/39) 68% (13/19) 1.5 0.4 to 5.2 (p = 0.49)
T/T 11.7% (2/17) 71% (5/7) 3 0.3 to 31.1 (p = 0.33)
*ORs of two or more genes methylated, with the first group being the referent group.
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Restricted use of albumin for
spontaneous bacterial peritonitis
Spontaneous bacterial peritonitis (SBP) may
precipitate deterioration of circulatory function
with severe hepatic insufficiency, hepatic ence-
phalopathy, and type-1 hepatorenal syndrome
(HRS) and has 30% hospital mortality despite
infection resolution.1 Predictors of this acute-
on-chronic liver failure include ascitic fluid
concentrations of granulocytes and cytokines
and renal and hepatic insufficiency at diag-
nosis.1–3 Endotoxemia and the inflammatory
response precipitate renal failure (RF) by
accentuating splanchnic vasodilatation and
impairing cardiac function.3–5 Compensatory
activation of the renin-angiotensin and sympa-
thetic nervous systems further decrease renal
perfusion. Volume expansion with albumin
(1.5 g/kg day one, 1 g/kg day three) signifi-
cantly reduces the incidence of HRS and
hospital mortality.2
In the sole reported trial, only patients with
serum bilirubin (bili) .68.4 mmol/l, blood urea
nitrogen (BUN).30 mg/dl or serum creatinine
(Cr) .88.4 mmol/l appeared to benefit from
albumin.2 In this report we describe a ther-
apeutic protocol involving 38 episodes in 28
patients at the Mount Sinai Medical Center
New York and the Barcelona Hospital Clinic in
which albumin (1.5 g/Kg on the day of
diagnosis, 1 g/Kg on the third day; Human
Albumin 25%, ZBL Bioplasma AG, Berne,
Switzerland) was restricted to those at high
risk for RF (bili . 68.4 mmol/l or Cr
.88.4 mmol/l) (table 1). Diagnosis and treat-
ment of SBP were based on established guide-
lines.6 Cardiovascular and splanchnic
hemodynamics and the activity of the renin-
angiotensin system and inflammatory response
were assessed in 6 low-risk cases from
Barcelona at SBP diagnosis and resolution.3 7 8
A
B
C
D
S22 S23 S24 S25
U M U MU MU MU MU M
MGMT MF
ECAD MF
P16 MF
DAPK MF
P16 151 bp (U)
150 bp (M)
DAPK 106 bp (U)
100 bp (M)
MGMT 93 bp (U)
81 bp (M)
ECAD 97 bp (U)
116 bp (M)
Positive  ddH2O
S19 S20 S21 S22
U M U MU MU MU MU M
Positive  ddH2O
S20 S21 S22 S23
U M U MU MU MU MU M
Positive  ddH2O
Figure 1 Examples of polymerase chain reaction products of P16, DAPK, E-cadherin (ECAD) and O2-
methyl-guanine methyl transferase (MGMT) genes. The lower panel shows segments of the methylated
sequences of these gene products. Methylated cytosine residues that are unchanged are shown as
underlined.
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